| 000 | 01762 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517095040.0 | ||
| 264 | 0 | _c20170309 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a1559-0305 | ||
| 024 | 7 |
_a10.1007/s12033-016-9950-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSannikova, E P | |
| 245 | 0 | 0 |
_aThe Modified Heparin-Binding L-Asparaginase of Wolinella succinogenes. _h[electronic resource] |
| 260 |
_bMolecular biotechnology _cSep 2016 |
||
| 300 |
_a528-39 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAmino Acid Substitution |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAsparaginase _xadministration & dosage |
| 650 | 0 | 4 |
_aBacterial Proteins _xadministration & dosage |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aHeparin _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aK562 Cells |
| 650 | 0 | 4 |
_aLeukemia L5178 _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aRecombinant Proteins _xmetabolism |
| 650 | 0 | 4 |
_aWolinella _xenzymology |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aBulushova, N V | |
| 700 | 1 | _aCheperegin, S E | |
| 700 | 1 | _aGubaydullin, I I | |
| 700 | 1 | _aChestukhina, G G | |
| 700 | 1 | _aRyabichenko, V V | |
| 700 | 1 | _aZalunin, I A | |
| 700 | 1 | _aKotlova, E K | |
| 700 | 1 | _aKonstantinova, G E | |
| 700 | 1 | _aKubasova, T S | |
| 700 | 1 | _aShtil, A A | |
| 700 | 1 | _aPokrovsky, V S | |
| 700 | 1 | _aYarotsky, S V | |
| 700 | 1 | _aEfremov, B D | |
| 700 | 1 | _aKozlov, D G | |
| 773 | 0 |
_tMolecular biotechnology _gvol. 58 _gno. 8-9 _gp. 528-39 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12033-016-9950-1 _zAvailable from publisher's website |
| 999 |
_c26037464 _d26037464 |
||